Clinical Trials on Bone in Argentina

Total 321 results

Pontifical Catholic University of Argentina

Completed

Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America

Osteoporosis

Argentina
Hospital Italiano de Buenos Aires

Enrolling by invitation

Multicenter Validation Study of an Artificial Intelligence Tool for Automatic Classification of Chest X-rays

Pneumothorax | Pleural Effusion | Bone Fracture | Consolidation | Opacity

Argentina
Universidad Nacional de Córdoba

Completed

Periodontal Disease and Post-menopausal Osteoporosis

Osteoporosis | Osteopenia | Periodontal Disease

Argentina
Pfizer

Completed

A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo

Osteoporosis

Argentina
Zimmer Biomet

Completed

A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.

Tumor | Neuroma | Mandibular Fractures | Treacher Collins Syndrome | Facial Fracture | Fibrous Dysplasia | Hemifacial Microsomia | Miller Syndrome | Osteoma of Mandibular Condyle | Cleft Face | Nager Syndrome

Argentina
Bio Sidus SA

Unknown

Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo

Postmenopausal Osteoporosis With Pathological Fracture

Argentina
Universidad Nacional de Rosario

Completed

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

Osgood-Schlatter Disease

Argentina
Hospital Italiano de Buenos Aires

Completed

Drug Interactions and Hip Fracture Risk in Older Adults

Hip Fractures

Argentina
Warner Chilcott
Sanofi

Terminated

Bone Microarchitecture in Osteopenic Postmenopausal Women

Osteoporosis

United States, Argentina
Hospital Italiano de Buenos Aires

Active, not recruiting

Effect of Spinae Erector Block (ESP) and Gabapentin on Recovery and Length of Stay in Adolescent Spinal Fusion Patients

Adolescent Idiopathic Scoliosis

Argentina
Drugs for Neglected Diseases
PhinC Development

Completed

Pharmacokinetic Drug-Drug Interaction Study

Chagas Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Active, not recruiting

Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment

Chagas Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires
The Hospital for Sick Children; Thrasher Research Fund; Universidad Nacional... and other collaborators

Completed

Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

Chagas Disease

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease (LACTBENZ)

Chagas Disease | Lactation

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease (LACTNFX)

Chagas Disease | Lactation

Argentina
Bayer

Completed

Study on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Humans by a Bug, Using Information From Patient Medical Records in Argentina

Chagas' Disease

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Institutional Registry of Hip Fracture in the Elderly

Hip Fracture

Argentina
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
BioMarin Pharmaceutical

Completed

Lifetime Impact Study for Achondroplasia (LISA)

Achondroplasia

Argentina, Brazil, Colombia
Hospital de Niños R. Gutierrez de Buenos Aires

Completed

Congenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evaluation in Chagas Disease Treated Children

Chagas Cardiomyopathy | Chagas Disease

Argentina
Warner Chilcott

Completed

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Osteopenia

United Kingdom, Argentina, Australia, Canada, France, Germany, Switzerland
Drugs for Neglected Diseases
LAT Research

Completed

Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease (Pop PK Chagas)

Chagas' Disease

Argentina
RFS Pharma, LLC

Completed

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

HIV Infections

Argentina
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
Eli Lilly and Company
TransPharma Medical

Completed

A Study for the Transdermal Application of Teriparatide

Osteoporosis

Hungary, Romania, Mexico, Argentina, Estonia
Austral University, Argentina

Unknown

Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C

Argentina
Shire

Completed

Open Label Extension (TRES)

Osteoporosis

United States, Argentina
Hospital Nacional Profesor Alejandro Posadas

Recruiting

Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation. (HINDIP)

Inflammation | Hyponatremia | Dengue

Argentina
University of Miami
National Institute of Mental Health (NIMH); Fundacion Huesped, Buenos Aires... and other collaborators

Completed

Positive Connections: COPA2

Human Immunodeficiency Virus

Argentina
Novartis Pharmaceuticals

Terminated

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection (REVERT)

Recurrent Hepatitis C

Argentina
ViiV Healthcare
GlaxoSmithKline

Completed

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Infection, Human Immunodeficiency Virus

Argentina
Laboratorio Elea Phoenix S.A.
Drugs for Neglected Diseases

Recruiting

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease (NuestroBen)

Chagas Disease

Argentina
Ministry of Public Health, Argentina
Centers for Disease Control and Prevention; Pan American Health Organization

Enrolling by invitation

Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in Argentina

Yellow Fever

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires

Recruiting

Implementation Strategy of Bio-molecular Techniques for Early Diagnose of Congenital Syphilis and Chagas Diseases

Chagas Disease | Syphilis

Argentina
Bayer

Completed

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Chagas Disease

Argentina
Bayer

Completed

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients

Chagas Disease

Argentina
Bayer

Completed

Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients

Chagas Disease

Argentina
Instituto Nacional de Parasitologia Dr. Mario Fatala...
Drugs for Neglected Diseases; National Council of Scientific and Technical... and other collaborators

Completed

Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial (TRAENA)

Chagas Disease

Argentina
Alba Maria Ropero
Centers for Disease Control and Prevention; Ministry of Public Health, Argentina

Completed

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Vaccine Response Impaired

Argentina
Bayer

Completed

Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Dietary Habits Study

Chagas' Disease

Argentina
Ultragenyx Pharmaceutical Inc

Active, not recruiting

Tumor-induced Osteomalacia Disease Monitoring Program

Tumor-induced Osteomalacia (TIO)

United States, Argentina
Pedro Cahn
Abbott

Completed

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. (GARDEL)

HIV Infection

Argentina
Hospital Italiano de Buenos Aires

Completed

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

HIV Infection

Argentina
Laboratorio Elea Phoenix S.A.
Ministerio de Ciencia e Innovación, Spain

Completed

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Glioma | Neuroblastoma | Retinoblastoma | Wilm's Tumor | Ewing's Sarcoma

Argentina
Sanofi
Procter and Gamble

Completed

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Osteoporosis Postmenopausal

France, United States, Australia, Canada, Lebanon, South Africa, Czech Republic, Turkey, Argentina, Poland, United Kingdom
Laboratorio Elea Phoenix S.A.

Completed

Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.

Acquired Immunodeficiency Syndrome

Argentina
Medtronic Cardiac Rhythm and Heart Failure

Terminated

Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease

Heart Diseases | Chagas Disease

Colombia, Argentina
Austral University, Argentina

Unknown

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Hepatitis C | Cirrhosis | Antiviral Drug Adverse Reaction

Argentina
Fundacion GESICA
Merck Sharp & Dohme LLC

Recruiting

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Flavivirus Infections | Dengue

Argentina
Tulane University School of Public Health and Tropical...
University of California, San Diego; Institute for Clinical Effectiveness and...

Recruiting

Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age (BETTY)

Chagas Disease

United States, Argentina

Clinical Trials on Bone in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations